Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT India 100BT GolfBT Mindrush
News
markets
stocks
Shreekrishna Biotech Ltd
Shreekrishna Biotech Ltd

Shreekrishna Biotech Ltd Share Price

  • Sector: Finance (Small Cap)
  • Volume: 0
Aug 12, 2015 00:00 IST Open
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹141.40
₹-7.40 (-%)
141.40Low
Today’s Performance
141.40High
0.00Low
52 Week’s Performance
141.40High

bt_logoStock Performance

  • No records found!!!

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta-
  • 52-Week Low (₹)-
  • 52-Week High (₹)-
  • Price-to-Book (X)*13.67
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*-
  • Earnings Per Share (₹)-
  • Market Cap (₹ Cr.)*139.30
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today49:11Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today
India-UK FTA: Piyush Goyal Highlights Social Security Win For Indian Professionals3:47India-UK FTA: Piyush Goyal Highlights Social Security Win For Indian Professionals
India’s Bilateral Trade Game Plan | Sunil Bharti Mittal Exclusive4:32India’s Bilateral Trade Game Plan | Sunil Bharti Mittal Exclusive
Explained | India–UK FTA Signed | What Does This Landmark Deal Mean For Trade & Industry?17:29Explained | India–UK FTA Signed | What Does This Landmark Deal Mean For Trade & Industry?
Mayuresh Joshi Highlights Stocks & Sectors That Will Benefit From The India-UK Free Trade Agreement2:29Mayuresh Joshi Highlights Stocks & Sectors That Will Benefit From The India-UK Free Trade Agreement
Trump Slams Fed’s ‘Wasteful’ Renovation As Powell Pushes Back In Helmet Showdown4:22Trump Slams Fed’s ‘Wasteful’ Renovation As Powell Pushes Back In Helmet Showdown
Trump Thanks Tulsi Gabbard For Exposing Obama’s Role In 2016 Election3:36Trump Thanks Tulsi Gabbard For Exposing Obama’s Role In 2016 Election
India-UK FTA Signed | NSE CEO Ashish Chauhan On Market Impact & Strategic Gains19:13India-UK FTA Signed | NSE CEO Ashish Chauhan On Market Impact & Strategic Gains
ALL You Need To Know About NSDL IPO | Should You Subscribe? | NSDL IPO Analysis4:36All You Need To Know About NSDL IPO | Should You Subscribe? | NSDL IPO Analysis
Dr Mukesh Aghi On ‘Red Lines’ India Has Drawn & How Deal May Have Stalled On Trump’s Desk4:55Dr Mukesh Aghi On ‘Red Lines’ India Has Drawn & How Deal May Have Stalled On Trump’s Desk
View more

bt_logoFAQ's

What was Shreekrishna Biotech Ltd share price previously?
Shreekrishna Biotech Ltd share price was down by -% from the previous closing price of ₹-.
Who are peers of Shreekrishna Biotech Ltd?
The peers of Shreekrishna Biotech Ltd are Bajaj Finance Ltd, Bajaj Finserv Ltd, Jio Financial Services Ltd, Bajaj Holdings & Investment Ltd, Power Finance Corporation Ltd, Cholamandalam Investment & Finance Company Ltd, Shriram Finance Ltd, HDFC Asset Management Company Ltd, Muthoot Finance Ltd, REC Ltd.
Who is/are the promoter/promoters of Shreekrishna Biotech Ltd?
The promotor/promotors of Shreekrishna Biotech Ltd are Sadanand Mishra, Bijendra Singh, Shirish Agrawal, Dhaval Chandrakant Shah, Pradeep Shukla, Sunil Nerli.
What has been 52-week high of Shreekrishna Biotech Ltd stocks?
The highest price of Shreekrishna Biotech Ltd stock is ₹- in the last 52-week.
What is the share price of Shreekrishna Biotech Ltd (SHKRISHNAB) today on BSE?
As on Aug 12, 2015 Shreekrishna Biotech Ltd (SHKRISHNAB)’s share price on BSE is Rs 141.4
What is the market cap of Shreekrishna Biotech Ltd (SHKRISHNAB)?
The current market capitalisation of Shreekrishna Biotech Ltd (SHKRISHNAB) is 139.30 crores
What is Shreekrishna Biotech Ltd Share symbol?
The symbol of Shreekrishna Biotech Ltd is .
What is the PE ratio of Shreekrishna Biotech Ltd (SHKRISHNAB)?
The current PE ratio of Shreekrishna Biotech Ltd (SHKRISHNAB) is -.
What is the PB ratio of Shreekrishna Biotech Ltd (SHKRISHNAB)?
The current PB ratio of Shreekrishna Biotech Ltd (SHKRISHNAB) is 13.67.
Today’s High & Low share prices of Shreekrishna Biotech Ltd (SHKRISHNAB) on BSE?
Today, the share price of Shreekrishna Biotech Ltd (SHKRISHNAB) on BSE touched a high of Rs 141.4 and a low of Rs 141.4
What price did Shreekrishna Biotech Ltd (SHKRISHNAB) shares open on the BSE today?
On BSE, the share price of Shreekrishna Biotech Ltd (SHKRISHNAB) opened at Rs 141.4
What is the 52-week high of Shreekrishna Biotech Ltd (SHKRISHNAB)?
The 52-week high price of Shreekrishna Biotech Ltd (SHKRISHNAB) is Rs 141.40
What is the 52-week low of Shreekrishna Biotech Ltd (SHKRISHNAB)?
The 52-week low price of Shreekrishna Biotech Ltd (SHKRISHNAB) is Rs 0.00

bt_logoAbout Shreekrishna Bio

Shreekrishna Biotech Ltd, incorporated in the year 1983, has its registered office in B-17/18 OMShree Swati ManorCHS, NC Kelkar Rd Nr Plaze Cineme, Mumbai, Maharashtra, 400028, 9833778003. The main industry in which Shreekrishna Biotech Ltd operates is Finance & Investments.

Auditor/Auditors for Shreekrishna Biotech Ltd is/are Jain Vinay & Associates. In the main management, is chairman and is the company secretary for Shreekrishna Biotech Ltd.

  • SM
    Sadanand MishraDirector
  • BS
    Bijendra SinghAdditional Director
  • SA
    Shirish AgrawalAdditional Director
  • DCS
    Dhaval Chandrakant ShahAdditional Director
  • PS
    Pradeep ShuklaAdditional Director
  • SN
    Sunil NerliAdditional Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.